Refresher Course: Abdominal and Gastrointestinal
RC 1201 - Clinical guidelines for the management of primary focal liver tumours: lost in translation?
Lectures
1
Chairperson's introduction
05:00Maria Carmen Ayuso Colella, Barcelona / ES
2
Diagnosis and management of benign liver lesions
15:00Cäcilia Reiner, Zürich / CH
3
Diagnosis and management of HCC and indeterminate lesions in the cirrhotic liver
15:00Maxime Ronot, Paris / FR
4
Management of HCC: interventional or surgical treatment (EASL)
15:00Thomas Karl Helmberger, Munich / DE
5
Panel discussion: The benefit of clinical guidelines in the MDT discussion
10:00Panel discussion: The benefit of clinical guidelines in the MDT discussion
5 min
Chairperson's introduction
Maria Carmen Ayuso Colella, Barcelona / Spain
15 min
Diagnosis and management of benign liver lesions
Cäcilia Reiner, Zürich / Switzerland
1. To diagnose benign liver tumours in the non-cirrhotic liver.
2. To choose the appropriate diagnostic workup.
3. To apply current management guidelines for benign liver tumours.
2. To choose the appropriate diagnostic workup.
3. To apply current management guidelines for benign liver tumours.
15 min
Diagnosis and management of HCC and indeterminate lesions in the cirrhotic liver
Maxime Ronot, Paris / France
1. To understand the process of hepatocarcinogenesis and how it translates into imaging.
2. To describe the concept of imaging-based noninvasive diagnosis of HCC.
3. To describe the most recent versions of the main diagnostic systems in cirrhotic patients.
4. To discuss the complementary role of biopsy and imaging.
5. To discuss the concept of prognostic imaging and how it can help with the management of patients.
2. To describe the concept of imaging-based noninvasive diagnosis of HCC.
3. To describe the most recent versions of the main diagnostic systems in cirrhotic patients.
4. To discuss the complementary role of biopsy and imaging.
5. To discuss the concept of prognostic imaging and how it can help with the management of patients.
15 min
Management of HCC: interventional or surgical treatment (EASL)
Thomas Karl Helmberger, Munich / Germany
1. To distinguish the disparities between interventional and surgical treatment modalities
for Hepatocellular Carcinoma (HCC) delineated in the EASL guidelines.
2. To recognise the pivotal clinical factors that impact the selection between interventional
and surgical interventions for the management of HCC.
3. To utilise the recommended strategies for both interventional and surgical approaches,
evaluating their suitability across diverse clinical scenarios.
for Hepatocellular Carcinoma (HCC) delineated in the EASL guidelines.
2. To recognise the pivotal clinical factors that impact the selection between interventional
and surgical interventions for the management of HCC.
3. To utilise the recommended strategies for both interventional and surgical approaches,
evaluating their suitability across diverse clinical scenarios.
10 min
Panel discussion: The benefit of clinical guidelines in the MDT discussion